0001179110-21-006329.txt : 20210603 0001179110-21-006329.hdr.sgml : 20210603 20210603161805 ACCESSION NUMBER: 0001179110-21-006329 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210601 FILED AS OF DATE: 20210603 DATE AS OF CHANGE: 20210603 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Carter Percy H. CENTRAL INDEX KEY: 0001863024 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37359 FILM NUMBER: 21992715 MAIL ADDRESS: STREET 1: C/O BLUEPRINT MEDICINES CORPORATION STREET 2: 45 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Blueprint Medicines Corp CENTRAL INDEX KEY: 0001597264 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 45 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-374-7580 MAIL ADDRESS: STREET 1: 45 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 edgar.xml FORM 4 - X0306 4 2021-06-01 0 0001597264 Blueprint Medicines Corp BPMC 0001863024 Carter Percy H. C/O BLUEPRINT MEDICINES CORPORATION 45 SIDNEY STREET CAMBRIDGE MA 02139 0 1 0 0 Chief Scientific Officer Common Stock 2021-06-01 4 A 0 21843 0 A 21843 D Stock Option (Right to Buy) 89.16 2021-06-01 4 A 0 39200 0 A 2031-06-01 Common Stock 39200 39200 D The reported transaction involved the Reporting Person's receipt of a grant of 21,843 restricted stock units under the Issuer's 2020 Inducement Plan. This option vests with respect to 25% of the shares underlying the option on June 1, 2022 and as to an additional 1/48th of the shares underlying the option each month thereafter. /s/ Ariel Hurley, Attorney-in-Fact 2021-06-03